KIR2DL1 and esophageal squamous cell carcinoma: Effective elimination of Fn and inhibition of KIR2DL1 expression on CD8+ T cells may prolong the survival of ESCC patients, which is very important in the clinical treatment of ESCC and has broad application prospects.